Contrary, the interaction between ubiquitin-specific peptidase 24 (USP24) and GSDMB prevents the degradation of gasdermin B in bladder cancer, and this may be a potential therapeutic target in the future [34]. Here, GSDMB is linked to urinary bladder carcinoma.